|
Table 1: Predictive algorithms to specific features of MACARENHA. |
|||
|
Factor to evaluate |
Algorithm |
Construct variables |
Description |
|
Visceral adiposity and incidence of T2DM |
METS-IR |
Serum glucose, HDL-c, BMI, Triglycerides |
Non-insulin-based fasting scale for assessing insulin sensitivity validated against the euglycemic-hyperinsulinemic clamp (EHC) |
|
VAT |
METS-VF |
METS-IR, gender, waist circumference, height, age |
Scale in patients with Metabolic Syndrome predicting the incidence of T2DM and HBP, independently of BMI, in primary care |
|
MASLD |
FLI, MRE, or THE |
GGT, BMI, waist circumference, and triglycerides |
Requires validation |
|
Mood |
Beck Depression Questionnaire |
Symptoms and signs of depression and anxiety |
A simplified, self-applied, 21-item scale with four response options that considers the patient’s condition over the past two weeks |
|
BMI = body mass index. FLI = fatty liver index. GGT = gamma-glutamyl transferase. BP = high blood pressure. HDL = high-density lipoprotein. MASLD = metabolic dysfunction-associated steatotic liver disease. METS-IR = metabolic score for insulin resistance. METS-VF = metabolic score for visceral fat. MRE = magnetic resonance elastography. T2DM = type 2 diabetes mellitus. THE = transient hepatic elastography. VAT = visceral adipose tissue. |
|||